Literatuur

  1. Ngeow J. et al. Docetaxel is effective in heavily pretreated patients with disseminated nasopharyngeal carcinoma. Ann Oncol. 2011; 22(3):718-722
  2. Zhang Li et al. Gemcitabine and cisplatin verus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial. Lancet 2016; 388(10054):1883-1892
  3. Zhang Y. et al. Gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma. N Engl J Med. 2019; 381:1124-1135

Commissie BOM adviezen

Ga naar de commissie BOM adviezen over nasofarynxcarcinoom

Richtlijnen

Ga naar de richtlijn Hoofd-halstumoren in de FMS richtlijnen­database.